Zhou Lingling, Liu Yang, Wang Zhaojia, Liu Daiqi, Xie Bingxin, Zhang Yue, Yuan Meng, Tse Gary, Li Guangping, Xu Gang, Liu Tong
Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China.
Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China; Department of Cardiology, Tianjin Fourth Central Hospital, The Fourth Central Hospital Affiliated to Nankai University, The Fourth Center Clinical College of Tianjin Medical University, Tianjin 300140, People's Republic of China.
Life Sci. 2021 May 1;272:119240. doi: 10.1016/j.lfs.2021.119240. Epub 2021 Feb 16.
The mechanisms of atrial fibrillation (AF) in diabetes mellitus (DM) involve a complex interplay between increased oxidative stress, mitochondrial dysfunction and atrial remodeling. In this study, we examined the effects of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation on mitochondrial oxidative stress and atrial remodeling in a rabbit model of diabetes mellitus (DM).
Healthy rabbits were selected and randomly divided into control, diabetic and apocynin administration group. Parameters of echocardiography, atrial electrophysiology, oxidative stress and mitochondrial function were compared between the different groups.
Compared to the control group, the DM group showed higher activity of NADPH oxidase, increased oxidative stress, larger left atrial diameter, a reduction in atrial mean conduction velocity. These findings were associated with increased interstitial fibrosis of the atria and higher atrial fibrillation (AF) inducibility. Moreover, atrial ultrastructure and mitochondrial function such as the mitochondrial respiratory control rate (RCR) were impaired. NADPH oxidase inhibition using the pharmacological agent apocynin improved these changes.
NADPH oxidase activity plays an important role in mitochondrial oxidative stress, which is associated with AF inducibility by promoting adverse atrial remodeling. The NADPH oxidase inhibitor apocynin can prevent these pathological changes and may be a potential drug for AF treatment.
糖尿病(DM)中房颤(AF)的机制涉及氧化应激增加、线粒体功能障碍和心房重构之间的复杂相互作用。在本研究中,我们在糖尿病兔模型中研究了烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶激活对线粒体氧化应激和心房重构的影响。
选取健康家兔,随机分为对照组、糖尿病组和阿朴吗啡给药组。比较不同组之间的超声心动图、心房电生理、氧化应激和线粒体功能参数。
与对照组相比,糖尿病组显示NADPH氧化酶活性更高、氧化应激增加、左心房直径更大、心房平均传导速度降低。这些发现与心房间质纤维化增加和更高的房颤(AF)诱导率相关。此外,心房超微结构和线粒体功能,如线粒体呼吸控制率(RCR)受损。使用药物阿朴吗啡抑制NADPH氧化酶可改善这些变化。
NADPH氧化酶活性在线粒体氧化应激中起重要作用,通过促进不良心房重构与房颤诱导率相关。NADPH氧化酶抑制剂阿朴吗啡可预防这些病理变化,可能是一种潜在的房颤治疗药物。